Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 20 of 35

COMPLETED NA

Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF

NCT02456233

COMPLETED

Low Fluoroscopy Afib Ablation Registry

NCT02830750

COMPLETED Phase 1

Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

NCT02687256

COMPLETED Phase 4

Fibrinogen Concentrate vs Cryoprecipitate

NCT03014700

COMPLETED

Comparative Study of Menstrual Blood and Systemic Blood

NCT02740816

COMPLETED

Brain-Based Biomarkers in Response to TMS in MDD

NCT02843373

TERMINATED Phase 3

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

NCT02762266

COMPLETED Phase 1

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

NCT02512926

COMPLETED

Ocular and Vision Problems in Patients After Fontan Operation

NCT03170778

COMPLETED Early Phase 1

[18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica

NCT02753101

COMPLETED

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

NCT02691156

COMPLETED Early Phase 1

Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery

NCT04296266

COMPLETED NA

Strength Training Regimen for Normal Weight Diabetics

NCT02448498

TERMINATED Phase 1

Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

NCT02728700

COMPLETED NA

Genetic Basis of Rosacea Study (Control)

NCT02749786

COMPLETED Phase 1

CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

NCT02693080

COMPLETED Early Phase 1

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

NCT02683824

COMPLETED

Longitudinal Gene Expression Profiling in Adults After Traumatic Injury

NCT02656459

COMPLETED Phase 1

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

NCT02745678

COMPLETED NA

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1

NCT02844543

COMPLETED

Food and the Brain

NCT02743000

COMPLETED Phase 4

Retinol on Human Skin Aging in East Asian Descent

NCT02906566

COMPLETED NA

Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

NCT02605187

COMPLETED Phase 3

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

NCT02601027

COMPLETED

Health Literacy in Adults With Congenital Heart Disease

NCT03170024

COMPLETED Phase 1

FDA Approved Medication to Reduce Binge Eating and/or Purging

NCT02553824

COMPLETED NA

Does Knowing One's Estimated Colorectal Cancer Risk Influence Screening Behavior?

NCT03819920

COMPLETED NA

Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP

NCT03074201

COMPLETED NA

Tobacco Treatment for Employable Californians, Total IMPACT Study

NCT02478697

COMPLETED NA

Brain Training in Children With/At-risk for Attention-Deficit/Hyperactivity Disorder and Executive Function Impairment

NCT02588365

COMPLETED NA

Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms

NCT03055156

COMPLETED NA

High Resolution Wavefront-guided vs. Wavefront Optimized LASIK

NCT02565537

COMPLETED NA

Brain Training in Preterm Children at Risk for Inattention, Hyperactivity, and Executive Function Impairment

NCT02588391

COMPLETED

Genetic Biomarkers of Executive Stress

NCT02933203

TERMINATED Phase 4

PIEB vs CEI for Labor Analgesia: An MLAC Study

NCT02573597

TERMINATED

Controlled Ventilation CT in CF Infants

NCT01200888

COMPLETED Phase 4

Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder

NCT02527564

COMPLETED

Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department

NCT03131609

TERMINATED NA

Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation

NCT02498444

COMPLETED

Point-of-Care System for Determination of Bilirubin Capacity in Neonates

NCT02612207

COMPLETED NA

Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)

NCT02748070

COMPLETED NA

Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers

NCT02533726

COMPLETED

Correlation Between Oocyte and Embryo Mechanical Properties on Embryo Development and Clinical Pregnancy After In Vitro Fertilization

NCT02530892

COMPLETED NA

On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients

NCT02519946

COMPLETED NA

Transciptomic Modification Induced by miRNAs in Endometrial Fluid

NCT02554539

COMPLETED NA

Integrating Combined Therapies for Persons With Co-occurring Disorders

NCT02598518

COMPLETED NA

Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study

NCT02137902

COMPLETED Phase 1

68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer

NCT02488070

COMPLETED NA

A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians

NCT02266576

COMPLETED Phase 4

Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6

NCT02480166

← Previous Page 20 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.